BELLOMO, GIOVANNI
BELLOMO, GIOVANNI
DIPARTIMENTO DI MEDICINA E CHIRURGIA
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
2020 Bellomo, Giovanni; Paolini Paoletti, Federico; Chipi, Elena; Petricciuolo, Maya; Simoni, Simone; Tambasco, Nicola; Parnetti, Lucilla
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
2022 Barba, L.; Paolini Paoletti, F.; Bellomo, G.; Gaetani, L.; Halbgebauer, S.; Oeckl, P.; Otto, M.; Parnetti, L.
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity?
2021 Sciaccaluga, M.; Megaro, A.; Bellomo, G.; Ruffolo, G.; Romoli, M.; Palma, E.; Costa, C.
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
2021 Paciotti, Silvia; Stoops, Erik; François, Cindy; Bellomo, Giovanni; Eusebi, Paolo; Vanderstichele, Hugo; Chiasserini, Davide; Parnetti, Lucilla
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease
2022 Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
2024 Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Thal, Dietmar R; Parnetti, Lucilla; Otto, Markus
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
2021 Delaby, C.; Teunissen, C. E.; Blennow, K.; Alcolea, D.; Arisi, I.; Amar, E. B.; Beaume, A.; Bedel, A.; Bellomo, G.; Bigot-Corbel, E.; Bjerke, M.; Blanc-Quintin, M. -C.; Boada, M.; Bousiges, O.; Chapman, M. D.; Demarco, M. L.; D'Onofrio, M.; Dumurgier, J.; Dufour-Rainfray, D.; Engelborghs, S.; Esselmann, H.; Fogli, A.; Gabelle, A.; Galloni, E.; Gondolf, C.; Grandhomme, F.; Grau-Rivera, O.; Hart, M.; Ikeuchi, T.; Jeromin, A.; Kasuga, K.; Keshavan, A.; Khalil, M.; Kortvelyessy, P.; Kulczynska-Przybik, A.; Laplanche, J. -L.; Lewczuk, P.; Li, Q. -X.; Lleo, A.; Malaplate, C.; Marquie, M.; Masters, C. L.; Mroczko, B.; Nogueira, L.; Orellana, A.; Otto, M.; Oudart, J. -B.; Paquet, C.; Paoletti, F. P.; Parnetti, L.; Perret-Liaudet, A.; Peoc'H, K.; Poesen, K.; Puig-Pijoan, A.; Quadrio, I.; Quillard-Muraine, M.; Rucheton, B.; Schraen, S.; Schott, J. M.; Shaw, L. M.; Suarez-Calvet, M.; Tsolaki, M.; Tumani, H.; Udeh-Momoh, C. T.; Vaudran, L.; Verbeek, M. M.; Verde, F.; Vermunt, L.; Vogelgsang, J.; Wiltfang, J.; Zetterberg, H.; Lehmann, S.
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
2020 Gaetani, L.; Paolini Paoletti, F.; Bellomo, G.; Mancini, A.; Simoni, S.; Di Filippo, M.; Parnetti, L.
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions
2024 Wojdała, Anna Lidia; Bellomo, Giovanni; Toja, Andrea; Gaetani, Lorenzo; Parnetti, Lucilla; Chiasserini, Davide
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment
2023 Paolini Paoletti, Federico; Gaetani, Lorenzo; Bellomo, Giovanni; Chipi, Elena; Salvadori, Nicola; Montanucci, Chiara; Mancini, Andrea; Filidei, Marta; Nigro, Pasquale; Simoni, Simone; Tambasco, Nicola; Di Filippo, Massimiliano; Parnetti, Lucilla
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases
2024 Barba, Lorenzo; Bellomo, Giovanni; Oeckl, Patrick; Chiasserini, Davide; Gaetani, Lorenzo; Torrigiani, Edoardo Guido; Paoletti, Federico Paolini; Steinacker, Petra; Abu-Rumeileh, Samir; Parnetti, Lucilla; Otto, Markus
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease
2023 Barba, Lorenzo; Abu-Rumeileh, Samir; Halbgebauer, Steffen; Bellomo, Giovanni; Paolini Paoletti, Federico; Gaetani, Lorenzo; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Parnetti, Lucilla; Otto, Markus
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
2024 Bellomo, Giovanni; Bayoumy, Sherif; Megaro, Alfredo; Toja, Andrea; Nardi, Giovanna; Gaetani, Lorenzo; Blujdea, Elena R.; PAOLINI PAOLETTI, Federico; Lidia Wojdaƚa, Anna; Chiasserini, Davide; van der Flier, Wiesje M.; Verberk, Inge M. W.; Teunissen, Charlotte; Parnetti, Lucilla
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy
2022 Paiella, M.; Salvadori, L.; Bellomo, G.; Manenti, T.; Ercolani, C.; Cornioli, L.; Chiappalupi, S.; Gentili, G.; Sorci, G.; Filigheddu, N.; Riuzzi, F
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay
2024 Bellomo, Giovanni; Toja, Andrea; PAOLINI PAOLETTI, Federico; Ma, Yihua; Farris, Carly M.; Gaetani, Lorenzo; Salvadori, Nicola; Chiasserini, Davide; Lidia Wojdaƚa, Anna; Concha-Marambio, Luis; Parnetti, Lucilla
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration?
2023 Parnetti, Lucilla; Bellomo, Giovanni; Compta, Yaroslau
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes
2023 Mancini, Andrea; Stoops, Erik; Demeyer, Leentje; Bellomo, Giovanni; Paolini Paoletti, Federico; Gaetani, Lorenzo; Di Filippo, Massimiliano; Parnetti, Lucilla
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders
2021 Bellomo, Giovanni; Indaco, Antonio; Chiasserini, Davide; Maderna, Emanuela; Paolini Paoletti, Federico; Gaetani, Lorenzo; Paciotti, Silvia; Petricciuolo, Maya; Tagliavini, Fabrizio; Giaccone, Giorgio; Parnetti, Lucilla; Di Fede, Giuseppe
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ?
2020 Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L.
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias
2023 Teunissen, Charlotte E; Kimble, Leighann; Bayoumy, Sherif; Bolsewig, Katharina; Burtscher, Felicia; Coppens, Salomé; Das, Shreyasee; Gogishvili, Dea; Gomes, Bárbara Fernandes; Gómez de San José, Nerea; Mavrina, Ekaterina; Meda, Francisco; Mohaupt, Pablo; Mravinacová, Sára; Waury, Katharina; Wojdała, Anna Lidia; Abeln, Sanne; Chiasserini, Davide; Hirtz, Christophe; Gaetani, Lorenzo; Bellomo, Giovanni; Halbgebauer, Steffen; Lehmann, Sylvain; Manberg, Anna; Nilsson, Peter; Otto, Markus; Vanmechelen, Eugeen; Verberk, Inge M W; Willemse, Eline; Zetterberg, Henrik
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies | 2020 | Bellomo, Giovanni; Paolini Paoletti, Federico; Chipi, Elena; Petricciuolo, Maya; Simoni, Simone; Tambasco, Nicola; Parnetti, Lucilla | |
| Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers | 2022 | Barba, L.; Paolini Paoletti, F.; Bellomo, G.; Gaetani, L.; Halbgebauer, S.; Oeckl, P.; Otto, M.; Parnetti, L. | |
| An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? | 2021 | Sciaccaluga, M.; Megaro, A.; Bellomo, G.; Ruffolo, G.; Romoli, M.; Palma, E.; Costa, C. | |
| Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement | 2021 | Paciotti, Silvia; Stoops, Erik; François, Cindy; Bellomo, Giovanni; Eusebi, Paolo; Vanderstichele, Hugo; Chiasserini, Davide; Parnetti, Lucilla | |
| Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease | 2022 | Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus | |
| Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease | 2024 | Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Thal, Dietmar R; Parnetti, Lucilla; Otto, Markus | |
| Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview | 2021 | Delaby, C.; Teunissen, C. E.; Blennow, K.; Alcolea, D.; Arisi, I.; Amar, E. B.; Beaume, A.; Bedel, A.; Bellomo, G.; Bigot-Corbel, E.; Bjerke, M.; Blanc-Quintin, M. -C.; Boada, M.; Bousiges, O.; Chapman, M. D.; Demarco, M. L.; D'Onofrio, M.; Dumurgier, J.; Dufour-Rainfray, D.; Engelborghs, S.; Esselmann, H.; Fogli, A.; Gabelle, A.; Galloni, E.; Gondolf, C.; Grandhomme, F.; Grau-Rivera, O.; Hart, M.; Ikeuchi, T.; Jeromin, A.; Kasuga, K.; Keshavan, A.; Khalil, M.; Kortvelyessy, P.; Kulczynska-Przybik, A.; Laplanche, J. -L.; Lewczuk, P.; Li, Q. -X.; Lleo, A.; Malaplate, C.; Marquie, M.; Masters, C. L.; Mroczko, B.; Nogueira, L.; Orellana, A.; Otto, M.; Oudart, J. -B.; Paquet, C.; Paoletti, F. P.; Parnetti, L.; Perret-Liaudet, A.; Peoc'H, K.; Poesen, K.; Puig-Pijoan, A.; Quadrio, I.; Quillard-Muraine, M.; Rucheton, B.; Schraen, S.; Schott, J. M.; Shaw, L. M.; Suarez-Calvet, M.; Tsolaki, M.; Tumani, H.; Udeh-Momoh, C. T.; Vaudran, L.; Verbeek, M. M.; Verde, F.; Vermunt, L.; Vogelgsang, J.; Wiltfang, J.; Zetterberg, H.; Lehmann, S. | |
| CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment | 2020 | Gaetani, L.; Paolini Paoletti, F.; Bellomo, G.; Mancini, A.; Simoni, S.; Di Filippo, M.; Parnetti, L. | |
| CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions | 2024 | Wojdała, Anna Lidia; Bellomo, Giovanni; Toja, Andrea; Gaetani, Lorenzo; Parnetti, Lucilla; Chiasserini, Davide | |
| CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment | 2023 | Paolini Paoletti, Federico; Gaetani, Lorenzo; Bellomo, Giovanni; Chipi, Elena; Salvadori, Nicola; Montanucci, Chiara; Mancini, Andrea; Filidei, Marta; Nigro, Pasquale; Simoni, Simone; Tambasco, Nicola; Di Filippo, Massimiliano; Parnetti, Lucilla | |
| CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases | 2024 | Barba, Lorenzo; Bellomo, Giovanni; Oeckl, Patrick; Chiasserini, Davide; Gaetani, Lorenzo; Torrigiani, Edoardo Guido; Paoletti, Federico Paolini; Steinacker, Petra; Abu-Rumeileh, Samir; Parnetti, Lucilla; Otto, Markus | |
| CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease | 2023 | Barba, Lorenzo; Abu-Rumeileh, Samir; Halbgebauer, Steffen; Bellomo, Giovanni; Paolini Paoletti, Federico; Gaetani, Lorenzo; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Parnetti, Lucilla; Otto, Markus | |
| Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts | 2024 | Bellomo, Giovanni; Bayoumy, Sherif; Megaro, Alfredo; Toja, Andrea; Nardi, Giovanna; Gaetani, Lorenzo; Blujdea, Elena R.; PAOLINI PAOLETTI, Federico; Lidia Wojdaƚa, Anna; Chiasserini, Davide; van der Flier, Wiesje M.; Verberk, Inge M. W.; Teunissen, Charlotte; Parnetti, Lucilla | |
| Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy | 2022 | Paiella, M.; Salvadori, L.; Bellomo, G.; Manenti, T.; Ercolani, C.; Cornioli, L.; Chiappalupi, S.; Gentili, G.; Sorci, G.; Filigheddu, N.; Riuzzi, F | |
| Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay | 2024 | Bellomo, Giovanni; Toja, Andrea; PAOLINI PAOLETTI, Federico; Ma, Yihua; Farris, Carly M.; Gaetani, Lorenzo; Salvadori, Nicola; Chiasserini, Davide; Lidia Wojdaƚa, Anna; Concha-Marambio, Luis; Parnetti, Lucilla | |
| Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? | 2023 | Parnetti, Lucilla; Bellomo, Giovanni; Compta, Yaroslau | |
| LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes | 2023 | Mancini, Andrea; Stoops, Erik; Demeyer, Leentje; Bellomo, Giovanni; Paolini Paoletti, Federico; Gaetani, Lorenzo; Di Filippo, Massimiliano; Parnetti, Lucilla | |
| Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders | 2021 | Bellomo, Giovanni; Indaco, Antonio; Chiasserini, Davide; Maderna, Emanuela; Paolini Paoletti, Federico; Gaetani, Lorenzo; Paciotti, Silvia; Petricciuolo, Maya; Tagliavini, Fabrizio; Giaccone, Giorgio; Parnetti, Lucilla; Di Fede, Giuseppe | |
| Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? | 2020 | Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L. | |
| Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias | 2023 | Teunissen, Charlotte E; Kimble, Leighann; Bayoumy, Sherif; Bolsewig, Katharina; Burtscher, Felicia; Coppens, Salomé; Das, Shreyasee; Gogishvili, Dea; Gomes, Bárbara Fernandes; Gómez de San José, Nerea; Mavrina, Ekaterina; Meda, Francisco; Mohaupt, Pablo; Mravinacová, Sára; Waury, Katharina; Wojdała, Anna Lidia; Abeln, Sanne; Chiasserini, Davide; Hirtz, Christophe; Gaetani, Lorenzo; Bellomo, Giovanni; Halbgebauer, Steffen; Lehmann, Sylvain; Manberg, Anna; Nilsson, Peter; Otto, Markus; Vanmechelen, Eugeen; Verberk, Inge M W; Willemse, Eline; Zetterberg, Henrik |